+280.8%
APP vs MRNA
-8.0%
+288.8%
-91.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.5% | -3.6% | +5.1% | +1.8% |
| 7D | +1.3% | -20.0% | +21.2% | +3.3% |
| 30D | +56.0% | -1.3% | +57.3% | +55.7% |
| 3M | +31.6% | +240.0% | -208.3% | +8.3% |
| 6M | -17.1% | +339.0% | -356.1% | -36.2% |
| YTD | -38.4% | +630.0% | -668.4% | -58.4% |
| 1Y | -25.5% | +769.1% | -794.6% | -51.9% |
| 3Y | +966.6% | +181.2% | +785.4% | +700.5% |
| 5Y | +280.8% | -8.1% | +288.9% | +260.7% |
| All | +280.8% | -8.0% | +288.8% | +260.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling